163 related articles for article (PubMed ID: 9081000)
1. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.
Pérez Gutthann S; García Rodríguez LA; Castellsague J; Duque Oliart A
BMJ; 1997 Mar; 314(7083):796-800. PubMed ID: 9081000
[TBL] [Abstract][Full Text] [Related]
2. Hormone replacement therapy and the risk of hospitalization for venous thromboembolism: a population-based study in southern Europe.
Varas-Lorenzo C; García-Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L; Perez-Gutthann S
Am J Epidemiol; 1998 Feb; 147(4):387-90. PubMed ID: 9508106
[TBL] [Abstract][Full Text] [Related]
3. Assessment of the risk for venous thromboembolism among users of hormone replacement therapy.
Oger E; Scarabin PY
Drugs Aging; 1999 Jan; 14(1):55-61. PubMed ID: 10069408
[TBL] [Abstract][Full Text] [Related]
4. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
5. Postmenopausal hormone replacement therapy and venous thromboembolism.
Wu O
Gend Med; 2005; 2 Suppl A():S18-27. PubMed ID: 16551553
[TBL] [Abstract][Full Text] [Related]
6. Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens.
Jick H; Derby LE; Myers MW; Vasilakis C; Newton KM
Lancet; 1996 Oct; 348(9033):981-3. PubMed ID: 8855853
[TBL] [Abstract][Full Text] [Related]
7. Differential association of oral and transdermal oestrogen-replacement therapy with venous thromboembolism risk.
Scarabin PY; Oger E; Plu-Bureau G;
Lancet; 2003 Aug; 362(9382):428-32. PubMed ID: 12927428
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.
Canonico M; Plu-Bureau G; Lowe GD; Scarabin PY
BMJ; 2008 May; 336(7655):1227-31. PubMed ID: 18495631
[TBL] [Abstract][Full Text] [Related]
9. Risk of venous thromboembolism in users of hormone replacement therapy.
Daly E; Vessey MP; Hawkins MM; Carson JL; Gough P; Marsh S
Lancet; 1996 Oct; 348(9033):977-80. PubMed ID: 8855852
[TBL] [Abstract][Full Text] [Related]
10. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.
Renoux C; Dell'Aniello S; Brenner B; Suissa S
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):554-560. PubMed ID: 28326633
[TBL] [Abstract][Full Text] [Related]
11. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.
Laliberté F; Dea K; Duh MS; Kahler KH; Rolli M; Lefebvre P
Menopause; 2011 Oct; 18(10):1052-9. PubMed ID: 21775912
[TBL] [Abstract][Full Text] [Related]
12. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study.
Renoux C; Dell'aniello S; Garbe E; Suissa S
BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678
[TBL] [Abstract][Full Text] [Related]
13. Recent epidemiological studies of the association between hormone replacement therapy and venous thromboembolism. A review.
Castellsague J; Pérez Gutthann S; García Rodríguez LA
Drug Saf; 1998 Feb; 18(2):117-23. PubMed ID: 9512918
[TBL] [Abstract][Full Text] [Related]
14. Obesity and risk of venous thromboembolism among postmenopausal women: differential impact of hormone therapy by route of estrogen administration. The ESTHER Study.
Canonico M; Oger E; Conard J; Meyer G; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
J Thromb Haemost; 2006 Jun; 4(6):1259-65. PubMed ID: 16706969
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic drugs and risk of venous thromboembolism: nested case-control study.
Parker C; Coupland C; Hippisley-Cox J
BMJ; 2010 Sep; 341():c4245. PubMed ID: 20858909
[TBL] [Abstract][Full Text] [Related]
16. [Oral contraception and menopausal hormone replacement: effects on hemostasis and risk of venous thromboembolism].
Bounameaux H; de Moerloose P; Campana A
Schweiz Med Wochenschr; 1996 Oct; 126(41):1756-63. PubMed ID: 8966508
[TBL] [Abstract][Full Text] [Related]
17. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom.
Huerta C; Johansson S; Wallander MA; García Rodríguez LA
Arch Intern Med; 2007 May; 167(9):935-43. PubMed ID: 17502535
[TBL] [Abstract][Full Text] [Related]
18. Testosterone treatment and risk of venous thromboembolism: population based case-control study.
Martinez C; Suissa S; Rietbrock S; Katholing A; Freedman B; Cohen AT; Handelsman DJ
BMJ; 2016 Nov; 355():i5968. PubMed ID: 27903495
[TBL] [Abstract][Full Text] [Related]
19. Use of hormone replacement therapy and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2019 Jan; 364():k4810. PubMed ID: 30626577
[TBL] [Abstract][Full Text] [Related]
20. Hormone replacement therapy and risk for venous thromboembolism: what's new and how do these findings influence clinical practice?
Douketis J
Curr Opin Hematol; 2005 Sep; 12(5):395-400. PubMed ID: 16093786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
